SPERO CANTAB UK LIMITED

active Private Limited Company

🇬🇧 GB | Incorporated 2016-05-11 | Reg. 10175336 | Data as of 2026-06-01

72110 - Research and experimental development on biotechnology

SPERO CANTAB UK LIMITED is a private limited company registered in the United Kingdom, under 10175336, incorporated on 11 May 2016. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 10 years. Registered office address: EC2Y 5EB London, the United Kingdom. Directors include ANKIT ATUL MAHADEVIA. Sole shareholder is Spero Therapeutics, Inc. Associated with 1 related entity, including SPERO EUROPE LIMITED. Confirmation statement next due 2026-05-24, overdue as of 2026-06-01. Data sourced from UK Companies House.

bookmark_add Save this entity to a watchlist · Get alerts on changes · API access

Official Identifiers

REGISTRATION NUMBER 10175336

Registered Address

6TH FLOOR
ONE LONDON WALL
EC2Y 5EB LONDON
the United Kingdom

Signal Intelligence (1)

Type	Severity	Description	Detected
confirmation statement overdue	MEDIUM	Confirmation statement next due 2026-05-24, overdue as of 2026-06-01	—

Key Management & Controllers

person ANKIT ATUL MAHADEVIA

DIRECTOR

Spero Therapeutics, Inc

75-100% SHAREHOLDER

Associated Entities

Companies sharing one or more directors or officers with this entity.

🇬🇧 SPERO EUROPE LIMITED

Source Records (1)

companieshouse

10175336

2026-06-01

open_in_new